Drug intelligence / Profile preview

VipAlbumin Gel

Development stage: Unknown
Lead developer: Royal Medicalink Pharmalab
Administration: Topical

Overview

VipAlbumin Gel is a topical gel formulation developed by Royal Medicalink Pharmalab. Its key active ingredient is Channa striata (snakehead fish) extract, which serves as a natural source of bio-albumin and essential proteins. The gel is designed to maintain a moist environment to facilitate wound healing, support tissue repair, and moisturize the skin. It is used for the care of various skin conditions, including burns, diabetic wounds, post-operative wounds, and general skin dryness.

Brand names: VipAlbumin Gel

Beyond the preview

Go deeper on VipAlbumin Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VipAlbumin Gel.

Explore the full profile